BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24138801)

  • 1. ¹H NMR-based metabolic profiling of human rectal cancer tissue.
    Wang H; Wang L; Zhang H; Deng P; Chen J; Zhou B; Hu J; Zou J; Lu W; Xiang P; Wu T; Shao X; Li Y; Zhou Z; Zhao YL
    Mol Cancer; 2013 Oct; 12(1):121. PubMed ID: 24138801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H-NMR based metabonomic profiling of human esophageal cancer tissue.
    Wang L; Chen J; Chen L; Deng P; Bu Q; Xiang P; Li M; Lu W; Xu Y; Lin H; Wu T; Wang H; Hu J; Shao X; Cen X; Zhao YL
    Mol Cancer; 2013 Apr; 12():25. PubMed ID: 23556477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
    Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
    BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Li Y; Wang C; Li D; Deng P; Shao X; Hu J; Liu C; Jie H; Lin Y; Li Z; Qian X; Zhang H; Zhao Y
    Oncol Rep; 2017 Nov; 38(5):3044-3054. PubMed ID: 28901465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy.
    Shao W; Gu J; Huang C; Liu D; Huang H; Huang Z; Lin Z; Yang W; Liu K; Lin D; Ji T
    Mol Cancer; 2014 Aug; 13():197. PubMed ID: 25163530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
    Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
    Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.
    Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y
    Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Akhtar MT; Samar M; Shami AA; Mumtaz MW; Mukhtar H; Tahir A; Shahzad-Ul-Hussan S; Chaudhary SU; Kaka U
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomic characteristics and biomarker research of human lung cancer tissues by HR1H NMR spectroscopy.
    Chen W; Lu S; Ou J; Wang G; Zu Y; Chen F; Bai C
    Cancer Biomark; 2016 Mar; 16(4):653-64. PubMed ID: 27002768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.
    Tripathi P; Somashekar BS; Ponnusamy M; Gursky A; Dailey S; Kunju P; Lee CT; Chinnaiyan AM; Rajendiran TM; Ramamoorthy A
    J Proteome Res; 2013 Jul; 12(7):3519-28. PubMed ID: 23731241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells.
    Huang C; Deng W; Xu HZ; Zhou C; Zhang F; Chen J; Bao Q; Zhou X; Liu M; Li J; Liu C
    Comput Struct Biotechnol J; 2023; 21():1606-1620. PubMed ID: 36874158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.
    Song H; Peng JS; Dong-Sheng Y; Yang ZL; Liu HL; Zeng YK; Shi XP; Lu BY
    Braz J Med Biol Res; 2012 Jan; 45(1):78-85. PubMed ID: 22124703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.
    Seierstad T; Røe K; Sitter B; Halgunset J; Flatmark K; Ree AH; Olsen DR; Gribbestad IS; Bathen TF
    Mol Cancer; 2008 Apr; 7():33. PubMed ID: 18439252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading of endometrial cancer using
    Skorupa A; Poński M; Ciszek M; Cichoń B; Klimek M; Witek A; Pakuło S; Boguszewicz Ł; Sokół M
    Sci Rep; 2021 Sep; 11(1):18160. PubMed ID: 34518615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Variations between Low-Grade and High-Grade Gliomas-Profiling by
    Jothi J; Janardhanam VA; Krishnaswamy R
    J Proteome Res; 2020 Jun; 19(6):2483-2490. PubMed ID: 32393032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.